Farzad Azimpour is a health technology designer and cardiologist serving as Chief Medical Officer at MYIA Labs, Adjunct Professor at Stanford University School of Medicine, and Assistant Director of Design at Stanford Biodesign.

In partnership with the American College of Cardiology, Dr. Azimpour leads cardiovascular design operations at MYIA Labs developing a computational platform to passively detect physiologic and behavioral signals of presymptomatic heart failure decompensation and introduce new embodiments of precision medicine decision-making.

Academically, he teaches and facilitates design strategy for Stanford Biodesign fellows and students, and he co-directs with Dr. Abraham Verghese the Stanford Medicine course titled MED267 on design for the human experience in medicine. In parallel, he is a contributor to the Stanford Presence 5 research team designing the future of human clinical interactions in an increasingly digital ecosystem.

Prior to his current roles, Dr. Azimpour served as Director of Health at the global design and innovation firm IDEO, where he remains an advisor to the health and medical practice. He was the 2014 St. Jude Medical and Dean's Innovation Fellow at Stanford Biodesign after completing his clinical training in internal medicine and cardiology at Cleveland Clinic and the University of Minnesota's Lillehei Heart Institute. He served as Chief Cardiology Fellow and was awarded an NIH fellowship in advanced cardiovascular technologies where he ran feasibility studies on acoustic detection of coronary artery stenosis, augmented vascular access, and implantable cardio-embolic stroke protection systems.

Dr. Azimpour holds a Bachelor's degree in Biological Sciences from The University of Texas at Austin, a Doctor of Medicine (MD) degree from The University of Texas Medical Branch, and a post-doctoral designation in Biodesign from Stanford University School of Medicine.

He is a recipient of Phi Beta Kappa distinction and the Arnold P. Gold Foundation Humanism in Medicine Award.